Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
HLN: Haleon plc Stock Analysis | finqOS
Healthcare · Drug Manufacturers - Specialty & Generic
The Story
HLN
The Story
HLN
Loading chart data...
Current State
Balance holding
The verdict
Good business
Mixed
Revenue growth
-0.6% / yr
Operating margin
21.9%
ROIC
6.6%
Financially safe
Stretched
Debt / equity
0.52×
Interest coverage
0.0×
Current ratio
0.92×
Valuation
Unrated
P/E ratio
19.6×
Dividend yield
2.0%
Haleon plc
HLN
New York Stock Exchange
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Haleon plc
HLN
New York Stock Exchange
·
USD
·
Closed
$9.87
−2.37%
$9.87
−$0.24 (2.37%)
52W Range
46th
pctl
Volume
0.97×
avg
Mkt Cap
43.47B
USD
P/E
19.6
TTM
Div Yield
1.95%
ann
52W Range
46th
pctl
Volume
0.97×
avg
Market Cap
43.47B
USD
P/E Ratio
19.6
TTM
Div Yield
1.95%
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings